Sign in
CompletedNo phase

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Key facts

Who runs it
Novartis Pharmaceuticals
Where
South Korea8 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
135 people enrolled
Started
12 Jan 2023
Ended
15 Apr 2025
Type of study
Observational
Treatments tested
  • Xolair
Record updated
29 May 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adults aged ≥18 years
  • Patients with CRSwNP who are not adequately controlled with conventional therapy (INCS)
  • Patients prescribed with Xolair® as per the locally approved label information
  • Patients who provide written informed consent to participate in the study

Who cannot take part

  • Contraindications listed in the locally approved label information of Xolair®; Hypersensitivity to the active ingredient or any other ingredient of Xolair®; Patients with myocardial infarction or history of myocardial infarction (pre-filled syringes only)
  • Patients who do not provide consent to participate in the study
  • Patients participating in other clinical trial

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the safety and effectiveness of Xolair® in patients with chronic rhinosinusitis with nasal polyps in routine clinical practice.

The group in the trial

  • Xolair

    patients who prescribed with Xolair according to the current label information in Korea.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Regulatory Post-Marketing Surveillance (rPMS) of Xolair® (Xolair® 150mg Powder for Solution for Injection, Xolair® 150mg/1ml Liquid in Pre-filled Syringe, Xolair® 75mg/0.5ml Liquid in Pre-filled Syringe) for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Record updated
29 May 2026